Cargando…
Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice
BACKGROUND: Epidermolysis bullosa acquisita (EBA) is a rare skin blistering disease with a prevalence of 0.2/ million people. EBA is characterized by autoantibodies against type VII collagen. Type VII collagen builds anchoring fibrils that are essential for the dermal-epidermal junction. The pathoge...
Autores principales: | Schönig, Sarah, Recke, Andreas, Hirose, Misa, Ludwig, Ralf J, Seeger, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703300/ https://www.ncbi.nlm.nih.gov/pubmed/23800341 http://dx.doi.org/10.1186/1750-1172-8-93 |
Ejemplares similares
-
Epidermolysis bullosa acquisita()
por: Miyamoto, Denise, et al.
Publicado: (2022) -
Epidermolysis Bullosa Acquisita: The 2019 Update
por: Koga, Hiroshi, et al.
Publicado: (2019) -
Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients
por: Iwata, Hiroaki, et al.
Publicado: (2018) -
Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita
por: Ludwig, Ralf J.
Publicado: (2013) -
Epidermolysis bullosa acquisita: current diagnosis and therapy
por: Mehren, Christine R., et al.
Publicado: (2011)